WST West Pharmaceutical Services

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With almost 10,000 team members across 50 sites worldwide, West helps support its customers by delivering over 40 billion components and devices each year.

Company profile

Eric Green
Fiscal year end
Former names
IRS number

WST stock data



30 Jul 21
31 Jul 21
31 Dec 21
Quarter (USD)
Jun 21 Mar 21 Dec 20 Sep 20
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
30 Jun 21 Buthman Mark A Phantom Stock Unit Common Stock Grant Aquire A No No 359.1 63 22.62K 10,778.3
21 Jun 21 Birkett Bernard Common Stock Payment of exercise Dispose F No No 357.59 1,090 389.77K 11,569
10 May 21 Silji Abraham Common Stock Sell Dispose S No No 335 2,171 727.29K 6,077.3
5 May 21 Chad Winters Common Stock Payment of exercise Dispose F No No 328.6 10 3.29K 705.777
4 May 21 Michels Douglas A Common Stock Grant Aquire A No No 0 577 0 42,288.05

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

91.9% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 572 578 -1.0%
Opened positions 73 86 -15.1%
Closed positions 79 69 +14.5%
Increased positions 216 233 -7.3%
Reduced positions 197 191 +3.1%
13F shares
Current Prev Q Change
Total value 19.12B 19.47B -1.8%
Total shares 67.86M 68.73M -1.3%
Total puts 88.6K 72.2K +22.7%
Total calls 65.3K 59.5K +9.7%
Total put/call ratio 1.4 1.2 +11.8%
Largest owners
Shares Value Change
Vanguard 8.46M $2.39B +2.1%
BLK Blackrock 7.47M $2.1B +2.4%
TROW T. Rowe Price 5.01M $1.41B +8.4%
BEN Franklin Resources 3.67M $1.03B -4.7%
STT State Street 3.3M $928.49M -1.6%
APG Asset Management 2.34M $658.7M +96.6%
WCM Investment Management 1.67M $471.33M +3.7%
IVZ Invesco 1.51M $426.3M -12.3%
ATAC Neuberger Berman 1.35M $377.3M -18.1%
Geode Capital Management 1.3M $365.06M +3.3%
Largest transactions
Shares Bought/sold Change
APG Asset Management 2.34M +1.15M +96.6%
Norges Bank 0 -745.96K EXIT
TROW T. Rowe Price 5.01M +388.8K +8.4%
ProShare Advisors 388.7K +373.23K +2412.3%
Alliancebernstein 106.65K -330.38K -75.6%
ATAC Neuberger Berman 1.35M -298.21K -18.1%
FMR 908.72K -270.43K -22.9%
California Public Employees Retirement System 549.4K +270.05K +96.7%
AMP Ameriprise Financial 112.66K -240.76K -68.1%
IVZ Invesco 1.51M -213.03K -12.3%

Financial report summary

Management Discussion
  • We evaluate the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that we consider not representative of ongoing operations. Such items are referred to as other unallocated items for which further information can be found above in the reconciliation from U.S. GAAP to non-U.S. GAAP financial measures.
  • Percentages in the following tables and throughout the Results of Operations section may reflect rounding adjustments.
Content analysis
H.S. freshman Avg
New words: deduction, enacted, Kingdom, month, withholding
Removed: April, back, dosing, January, recall, September, unpredictable, voluntary